Veterans and Servicemembers PTSD Emerging Treatment Review Act of 2026
Key claim: The Veterans and Servicemembers PTSD Emerging Treatment Review Act of 2026 (HR9547) would establish a review of emerging treatments for post-traumatic stress disorder among veterans and servicemembers.
Abstract
(HR9547 · 119th Congress) Latest action (2026-06-30): Referred to the House Committee on Armed Services.
Why this matters
The bill signals continued congressional interest in expanding DoD/VA evaluation of novel PTSD therapies (potentially including psychedelic-assisted and other emerging modalities) for a population with persistently high behavioral-health burden. As a review mandate rather than a treatment authorization, its practical impact depends on scope, reporting deadlines, and whether findings feed into TRICARE/VA coverage or DoD clinical trial funding.